Inseego Unveils the Ultimate 5G Industrial Gateway
22.7.2021 15:30:00 EEST | Business Wire | Press release
Inseego Corp. (NASDAQ: INSG), a leader in 5G device-to-cloud solutions, today introduced its Wavemaker PRO 2000e industrial gateway. Combining high-performance 5G with the most advanced 4G LTE capabilities, this solution delivers best-in-class throughput and reliability for industrial IoT and enterprise networks.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210722005327/en/
(C)2021. Inseego Corp. All rights reserved. 5G industrial gateway S2000e.
“We designed the S2000e to provide the best possible 5G connection for any routing system or endpoint, with maximum speed, reliability and security,” said Inseego President Ashish Sharma. “It brings multi-gigabit performance to both on-premise and remote installations for industrial IoT networks, private networks, SD-WANs and other business networks.”
With enterprise-grade hardware features, cloud-based remote device management and advanced security capabilities, the S2000e is designed to ensure 24/7 business continuity and safeguard critical connections.
“The intersection of mobile, cloud and edge compute technology is driving a new era in 5G LAN innovation,” said Ozer Dondurmacıoğlu, VP of Marketing at Celona. “With its new S2000e gateway that supports advances such as concurrent 4G/5G carrier aggregation, Inseego is leading this charge delivering the high-performance connectivity, resilience and versatility that have become non-negotiable for enterprises actively building their own private cellular networks.”
In addition to supporting fixed installations, the S2000e is ideal for mobile installations, providing 5G/LTE and GPS for vehicular area networks. One great example is Shoreline Sightseeing, which operates the largest fleet of water taxis and tour boats in Chicago.
“The results we’ve seen on our vessels with the Wavemaker PRO S2000e have been outstanding,” said Ken Wagner, IT Manager for Shoreline Sightseeing. “We’re using these 5G gateways to provide WAN backhaul (cellular to ethernet) for the network routing systems on our boats, which connect our onboard POS systems and live streaming video feeds, and allow us to remotely retrieve video data from onboard DVRs. The speed and reliability we’re seeing from the S2000e is far better than any of the products we’ve used in the past.”
Continuous, multi-gigabit 5G connectivity
The S2000e is the only commercially available 5G industrial gateway with simultaneous 4x4 MIMO LTE and 5G connectivity, enabling faster throughput* and better coverage at all times, even when falling back to LTE.
It also provides a higher thermal threshold than other gateways. Advanced thermal management enables the S2000e to provide multi-gigabit 5G data rates continuously, without throttling the available sub-6 bandwidth or falling back to LTE due to internal temperatures. This is especially important for industrial environments with extreme temperatures, including installations where the S2000e is in a factory environment or inside an enclosure or cabinet.
The S2000e is available now and supports sub-6 GHz 5G and LTE (Cat 22). In addition, mmWave units are available for proof-of-concept for indoor mmWave use cases.
Downtime prevention
Mission-critical and business-critical networks can’t afford a minute of downtime. The S2000e features dual SIMs for both primary and backup connectivity with auto-switching for instantaneous failover. Active keepalive also monitors the WAN connection to ensure the device is always ready to pass traffic.
Maximum deployment flexibility
With 6 antenna ports and multiple antenna accessories, the S2000e can provide a strong signal almost anywhere. Users can attach dipole antennas for in-building coverage or pipe antennas outside of a building or enclosure for an even better signal. The 6 cellular antennas also allow the device to dedicate four ports to 4x4 MIMO and the other ports to 5G, making it the only device on the market capable of doing so.
It connects to any routing system or remote endpoint through its 5 Gb ethernet port or its 2.7 Gb USB-C port using DHCP (router mode or IPPT modem mode).
Support for PoE PD means the S2000e can be powered by another PoE device (routing system or PoE injector) so you can locate it almost anywhere.
A variety of mounting brackets enable installation on a desk, wall, pole, DIN rail or strut framing.
The Inseego mobile app also simplifies self-installation, from identifying the best location to setup, startup and more.
Device-to-cloud software for remote management and advanced security
The Wavemaker PRO 5G S2000e supports Inseego Connect™ device management for remote configuration, visibility and control of all deployed devices through a single console, helping to avoid data overage charges, ensure device health and more.
In addition to many built-in security features, Inseego Secure cloud-based software (available in Q3) provides active threat detection and alerts of any device-related anomalies.
Wavemaker PRO software offers quarterly feature enhancements and security updates over FOTA** to future-proof the S2000e, increasing its lifetime value.
Purpose-built for the most demanding applications
The S2000e is ideal for industrial and enterprise use cases such as:
- Manufacturing Equipment – Supports real-time monitoring and control systems in factories and other facilities, with high throughput, low latency and fewer wiring hassles.
- Energy & Utility Enclosures – Ideal for remote installations where wireline won’t work, including remote pump stations, meter readers, and more. High security and reliability for critical infrastructure.
- Remote Surveillance Enclosures – Supports multiple 4K video streams and provides the ability to leverage less congested parts of the network.
- State & Local Government WAN Connection – A great alternative to wireline for large offices and remote sites, the S2000e provides high-throughput backhaul for routing systems and access points.
- Education WAN Connection – Transmit live video streams from one teacher to multiple classrooms or distance learning locations using the S2000e for backhaul to the cellular network.
"The nexus of 5G and industrial IoT will change the way critical assets and infrastructure are managed, controlled and secured,” said Dan Shey, Managing Director and Vice President at ABI Research. “A go-anywhere enterprise-grade 5G gateway that can deliver continuous high throughput will be a must-have for many of these deployments.”
Trusted and secure
Designed and developed in the U.S., Inseego solutions are trusted by leading mobile operators, government agencies and enterprise customers worldwide.
Availability
The Wavemaker PRO 5G industrial gateway S2000e is now commercially available from Inseego.
The S2000e is certified for use on North American (FCC/PTCRB) and European (CE) private networks, and leading carrier networks in the U.S. (including Verizon and T-Mobile), and is available for general carrier approval in EU/UK (GCF) and AU/NZ (RCM/RSM).
To learn more about Inseego 5G products and solutions go to inseego.com. For press and analyst inquiries, please email press@inseego.com.
About Inseego Corp.
Inseego Corp. (Nasdaq: INSG) is an industry leader in smart device-to-cloud solutions that extend the 5G network edge, enabling broader 5G coverage, multi-gigabit data speeds, low latency and strong security to deliver highly reliable internet access. Our innovative mobile broadband, fixed wireless access (FWA) solutions and software platform incorporate the most advanced technologies (including 5G, 4G LTE, Wi-Fi 6 and others) into a wide range of products that provide robust connectivity indoors, outdoors and in the harshest industrial environments. Designed and developed in the USA, Inseego products and SaaS solutions build on the company’s patented technologies to provide the highest quality wireless connectivity for service providers, enterprises and government entities worldwide. www.inseego.com #Putting5GtoWork
__________________
*Actual speeds experienced are dependent on carrier network and coverage.
**FOTA opt-out is available.
©2021 Inseego Corp. All rights reserved. The Inseego name and logo are registered trademarks, and the Inseego Wavemaker and Inseego Connect names are trademarks of Inseego Corp. Other Company, product or service names mentioned herein are the trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210722005327/en/
Contact information
Inseego Media contact:
Anette Gaven
Tel: +1 (619) 993-3058
Anette.Gaven@inseego.com
Investor Relations contact:
Joo-Hun Kim, MKR Group
Tel: +1 (212) 868-6760
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
